Biotechnology company Advanced Enzyme Technologies announced Q2FY26 results Revenue from operations on consolidated basis increased to Rs 1,845 million in the Q2FY26 from Rs 1,461 million in the Q2FY25, a growth of 26%. Consolidated EBITDA during Q2FY26 stands at Rs 601 million as compared to Rs 424 million during Q2FY25, an increase of 42%. Profit before tax stands at Rs 595 million during Q2FY26 as against Rs 422 million in Q2FY25, an increase of 41%. Profit after tax grew by 34% and stands at Rs 447 million during Q2FY26 as compared to Rs 334 million during the Q2FY25. EBITDA margin stands at 33%, PBT margin stands at 32% and PAT margin stands at 24% during the quarter. Financial costs stood at Rs 7 million during Q2FY26 as against Rs 9 million in Q2FY25. Depreciation and Amortization charge for the Q2FY26 stood at Rs 101 million as compared to Rs 89 million in the same quarter previous year. Earnings Per Share during Q2FY26 stands at Rs 3.87 as compared to Rs 2.94 in Q2FY25. Result PDF